Counterfeit Drug Main Page » Resources

Resources

Look to this page as a substantive directory of various governmental and private organizations involved in the battle to stop the distribution of illegal and dangerous counterfeit drugs. You can also use this tool to connect to blogs and television segments which share personal experiences.

 

TitleDescription

The Cancer Blog The Cancer Blog- Blog on “Fake drugs: Counterfeit Drugs Sold as Prescription Drugs,” posted June 10, 2006.

RFID Weblog RFID Weblog- Blog on “FDA Counterfeit Drug Report Does Not Signal a Pull Back,” posted June 24, 2006.

National Prevention Council National Crime Prevention Council- Brochure advising people on how to protect themselves from counterfeit drugs.

The Turkewitz Law Firm’s counterfeit drug information page providing general facts and figures, congressional updates, links to other sites, etc.

Dangerous Doses Dangerous Doses- A website dedicated to the renowned book Dangerous Doses, written by Katherine Eban, as an investigative look into the world of counterfeit prescription drugs release May 9, 2005. Provides helpful information, news and articles, links, et

Medscape Today Medscape Today- Section on the website with various webpages regarding counterfeit drug issue: what the drugs are, magnitude of the issue, where the issue lies, etc.

National Consumer’s League National Consumer’s League- Contains fake drug faqs, tips for avoiding them, and resources to report suspect drugs.

BuySafeDrugs.info Sponsored by the Pharmaceutical Research and Manufacturers of America (PhRMA) to provide information on safe, legal ways patients can save on prescription drugs, to educate patients on the risks of importing medicines, and to explain why legalizing import

Healthcare Distribution Management Association Healthcare Distribution Management Association- Anti-counterfeiting page on their website, under both Government Affairs and Issues in Distribution links. HDMA is a member of the Partnership for Safe Medicines, a diverse network of organizations concerned

The Partnership for Safe Medicines This organization heads the Partnership for Safe Medicines, a diverse network of organizations concerned by the consumer safety threats posed by the purchase and use of unapproved, counterfeit, substandard, mishandled or otherwise unsafe medicines. The we

USPTO International Intellectual Property Profile Listing of links to organizations involved in international intellectual property protection issues, including Laws & Regulations, Enforcement, International Protection, International and Regional Organizations, and Other References.

Strategy Targeting Organized Piracy (STOP!) Initiative launched by the USPTO to combat the threat of counterfeit products. Includes a hotline as well as information to leverage the resources of the U.S. Government to secure and enforce trademarks, patents, and copyrights overseas.

StopFakes.gov USPTO's website devoted to the STOP! initiative. See below.

United States Patent and Trademark Office (USPTO) DOC agency responsible for issuing patents and trademarks.

United States Department of Commerce (DOC) Outlines FDA's efforts to combat the threat of counterfeit medicines. Includes links to the FDA Counterfeit Report and a discussion of RFID feasability.

United States Customs & Border Protection (CBP) Agency of the DHS responsible for managing, controlling and securing United States borders.

United States Department of Homeland Security (DHS Outlines FDA's efforts to combat the threat of counterfeit medicines. Includes links to the FDA Counterfeit Report and a discussion of RFID feasability.

United States Chamber Counterfeiting and Piracy Issues Center U.S. Chamber's global initiative to combat counterfeiting, recent anti-counterfeiting actions, and access to all counterfeit related site content.

United States Chamber of Commerce The world's largest not-for-profit business federation that, among other things, works to stop the spread of counterfeit products.

The Center for Medicines in the Public Interest (CMPI) Clearinghouse of information on the development, accessibility, and safety of pharmaceuticals.

WHO: Essential Drugs and Medicines Policy Links to 60 page brochure titled, Counterfeit drugs: Guidelines for the Development of Measures to Combat Counterfeit Drugs .

WHO: Substandard and Counterfeit Medicines Fact Sheet Defines substandard and counterfeit medicines, their consequences, and actions necessary to address them.

WHO: Counterfeit and Substandard Medicines Homepage WHO counterfeit and substandard medicines information, reports, and activities.

World Health Organization (WHO) Outlines FDA's efforts to combat the threat of counterfeit medicines. Includes links to the FDA Counterfeit Report and a discussion of RFID feasability.

FDA News: Drug Industry Daily Online FDA's online news digest of pharmaceutical industry related news. Updated daily .

FDA: Center for Biologics Research and Evaluation (CBER) Initiative Against Counterfeit Drugs FDA's July 2003 CBER Initiative to address the increasing concern about the possibility of potentially unsafe counterfeit drugs reaching consumers. Includes interim and final reports.

FDA: Combating Counterfeit Drugs Outlines FDA's efforts to combat the threat of counterfeit medicines. Includes links to the FDA Counterfeit Report and a discussion of RFID feasability.

United States Food & Drug Administration (FDA) Outlines FDA's efforts to combat the threat of counterfeit medicines. Includes links to the FDA Counterfeit Report and a discussion of RFID feasability.

FDA: Center for Biologics Research and Evaluation (CBER) Initiative Against Counterfeit Drugs FDA's July 2003 CBER Initiative to address the increasing concern about the possibility of potentially unsafe counterfeit drugs reaching consumers. Includes interim and final reports.

FDA: Combating Counterfeit Drugs Outlines FDA's efforts to combat the threat of counterfeit medicines. Includes links to the FDA Counterfeit Report and a discussion of RFID feasability.